愚愚学园 外文期刊互助 PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with

复制链接 | 浏览器收藏 | 打印

kuaidi334415

级别: 小愚愚

作者资料
发送短消息
加为好友

UID: 128120
精华: 0
发帖: 33
威望: -5 点积分转换
愚愚币: 165 YYB 在线充值
贡献值: 0 点
在线时间: 116(小时)
注册时间: 2019-02-23
最后登录: 2019-08-19

楼主发表于: 2019-03-08 09:19

只看楼主 | 小中大

PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with

【作者】Kanzaki R1,2, Naito H1, Kise K1, Takara K1, Eino D1, Minami M2, Shintani Y2, Funaki S2, Kawamura T2, Kimura T2, Okumura M2, Takakura N
    【文章标题】PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with  Cell Lung Cancer Treated with Surgery Following Preoperative Chemotherapy or Chemoradiotherapy
    【期刊名，年份，卷（期），起止页*****】Ann Surg Oncol. 2016 Nov;23(12):4093-4100. Epub 2016 Jul 5.
    【全文链接】PMID: 27380644 DOI: 10.1245/s10434-016-5392-z

顶端